Back

Assessing right ventricular dysfunction in wild-type transthyretin amyloid cardiomyopathy: echocardiographic predictor of clinical outcomes

11 December 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Poster session 2 Myocardial Disease EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Barbara Lage Garcia

Alto Ave Hospital Center, Guimaraes (Portugal)

71 More presentations in this session

Presentation thumbnail
Select episodes of acute cardiac rejection after orthotopic heart transplantation, not affecting the global longitudinal strain during a 2-year observation period
Miss Z. Zalewska (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
Left atrial phasic mechanics and structural predictors of target organ damage in dipper and non-dipper hypertension
Assistant Professor O. Seckin (Ankara, TR)
Abstract Slides
Presentation thumbnail
Anti-interleukin therapy for severe asthma and left atrial function improvement: a pilot study
Doctor M. Russo (Siena, IT)
Abstract Slides
Presentation thumbnail
Early prediction of atrial fibrillation using left atrial strain in STEMI patients: a prospective echocardiographic study
Doctor D. Raimoglou (Istanbul, TR) Doctor H. Verdiyev (Istanbul, TR)
Abstract
Presentation thumbnail
Prognosis values of 3D strain in untreated hypertension
Professor W. Tsai (Tainan, TW)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2

The Event

Event poster

EACVI 2025

11 December - 13 December 2025
You may be interested in
thumbnail
Congress Presentation
Echocardiography as first-line technique in suspected cardiac amyloidosis
thumbnail
Congress Presentation
Dilated cardiomyopathy
thumbnail
Congress Presentation
What is the best imaging method to assess myocardial viability? 

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources